The social value of lecanemab for patients with early Alzheimer's disease in Japan.
Saved in:
| Title: | The social value of lecanemab for patients with early Alzheimer's disease in Japan. |
|---|---|
| Authors: | Igarashi A; Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Azuma-Kasai M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tani M; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Utsumi T; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Shibahara H; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Inoue S; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan., Rothwell S; Eisai Europe Ltd., Hatfield, UK., Kamanaka G; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Sakata Y; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Hiyoshi H; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan., Tomita K; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan. |
| Source: | Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2026 Jul; Vol. 112 (1), pp. 283-301. Date of Electronic Publication: 2026 May 10. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42108615 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The social value of lecanemab for patients with early Alzheimer's disease in Japan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Igarashi+A%22">Igarashi A</searchLink>; Department of Health Policy and Public Health, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Azuma-Kasai+M%22">Azuma-Kasai M</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tani+M%22">Tani M</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Utsumi+T%22">Utsumi T</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shibahara+H%22">Shibahara H</searchLink>; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+S%22">Inoue S</searchLink>; Health Economics Research Department, CRECON Medical Assessment Inc., Shibuya, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Rothwell+S%22">Rothwell S</searchLink>; Eisai Europe Ltd., Hatfield, UK.<br /><searchLink fieldCode="AU" term="%22Kamanaka+G%22">Kamanaka G</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sakata+Y%22">Sakata Y</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hiyoshi+H%22">Hiyoshi H</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tomita+K%22">Tomita K</searchLink>; Global AD Value and Access/Patient Advocacy, Eisai Co. Ltd., Bunkyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229814863%22">Journal of Alzheimer's disease : JAD</searchLink> [J Alzheimers Dis] 2026 Jul; Vol. 112 (1), pp. 283-301. <i>Date of Electronic Publication: </i>2026 May 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9814863 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1875-8908 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213872877%22">13872877 </searchLink><i>NLM ISO Abbreviation: </i>J Alzheimers Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42108615 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/13872877261447312 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 283 Titles: – TitleFull: The social value of lecanemab for patients with early Alzheimer's disease in Japan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Igarashi A – PersonEntity: Name: NameFull: Azuma-Kasai M – PersonEntity: Name: NameFull: Tani M – PersonEntity: Name: NameFull: Utsumi T – PersonEntity: Name: NameFull: Shibahara H – PersonEntity: Name: NameFull: Inoue S – PersonEntity: Name: NameFull: Rothwell S – PersonEntity: Name: NameFull: Kamanaka G – PersonEntity: Name: NameFull: Sakata Y – PersonEntity: Name: NameFull: Hiyoshi H – PersonEntity: Name: NameFull: Tomita K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1875-8908 Numbering: – Type: volume Value: 112 – Type: issue Value: 1 Titles: – TitleFull: Journal of Alzheimer's disease : JAD Type: main |
| ResultId | 1 |